methotrexate
Etanercept may be superior to methotrexate in psoriatic arthritis
Etanercept alone or in combination with methotrexate, seems to work better than methotrexate monotherapy in people with psoriatic arthritis, according to recent study findings in Arthritis and Rheumatology. Continue reading
Methotrexate drug holiday may improve flu vaccine efficacy in rheumatoid arthritis
People with rheumatoid arthritis who stop taking methotrexate treatment for two weeks after they have a seasonal flu shot can improve the vaccine’s efficacy without increasing rheumatoid arthritis disease activity, according to new research presented at a US rheumatology conference. Continue reading
Methotrexate users: moderate drinking does not risk liver damage says new research
People receiving methotrexate can drink moderate amounts of alcohol without risking liver damage, according to a new study published in the Annals of the Rheumatic Diseases.
Methotrexate is often to prevent or limit disability and joint damage associated with rheumatoid arthritis. Continue reading
Treatment with etanercept and methotrexate for rheumatoid arthritis can be safely tapered, says study
A new study suggests that people with rheumatoid arthritis who responds positively to treatment with an etanercept and methotrexate-based therapeutic regimen may be able to reduce or even stop taking the drugs without seeing a negative impact on their overall outcome. Continue reading
People with rheumatoid arthritis less likely to stop using biologic therapies
Low number of people with rheumatoid arthritis quit treatment when they’re using biologic therapies, according to research published in RMD Open.
People discontinue therapies when they don’t work well enough or result in intolerable side effects. So a team compared discontinuation rates of first and second biologics in 2,281 people with rheumatoid arthritis by anti-TNF status. Continue reading
